Besides, we also observed a significant increase of tumor-infiltrating tissue-resident memory T cells (Figure S5A) and effector memory T cells (Figure S5B) in both CD4+ and CD8+ T cell subsets from combination-treated mice, revealing memory CD8+ /CD4+ T cells were activated after combination therapy. This evidence concerns the gene CD8A and neoplasm.